Tuesday, February 18, 2025 | 01:06 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Lupin launches Formoterol Fumarate Inhalation Solution in US market

Image

Capital Market
Lupin announced the launch of Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial, to market a generic equivalent of Perforomist Inhalation Solution, 20 mcg/2 mL, of Mylan Specialty, L.P.

Formoterol Fumarate Inhalation Solution (RLD Perforomist) had estimated annual sales of USD 268 million in the U.S. (IQVIA MAT September 2022).

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 29 2022 | 12:25 PM IST

Explore News